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ABSTRACT 
The role of estrogen on male reproductive function 
has become clearer in the last decade. During 
these years the study of the effect of testosterone, 
estrogen or an aromatase inhibitor in hypogonadal 
men provided a first evidence of the effects of 
estrogens in the regulation of gonadotropin secre- 
tion. At the same time, the development of a line of 
transgenic male mice lacking estrogen receptor (x, 
estrogen receptor I~ or aromatase gene provided 
further evidence about the role of estrogens not 
only in the regulation of gonadotropin secretion, 
but also on the effects of estrogens on testicular 
function and development. A confirmation of these 
actions of estrogens came from the observation of 
natural ly occurr ing mutat ions of the estrogen 
receptor and of the aromatase gene in human 
males. Based on these data it has been demonstra- 
ted that estrogens are major regulators of gonado- 
tropin secretion acting both at pituitary and hypota- 
lamic level. The presence in the human reproducti- 
ve structures of estrogen receptor ~, estrogen 
receptor I~ and the aromatase enzyme indicates the 
existence of receptor (x, estrogen receptor 6 or aro- 
matase estrogen actions at this level. Anyway, the 
precise role of estrogens in testicular development 
and function and on the regulation of human sper- 
matogenesis has not yet been precisely clarified. 
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I. INTRODUCTION 
The establishment of estrogen role in male reproduction is 
a very recent acquisition i  endocrinology [27]. 
The study of transgenic mice lacking functional estrogen 
receptors or functional aromatase nzyme permitted to 
shed new light into the role of estrogens on male repro- 
duction [6]. Again, the discovery of human mutations in 
both the estrogen receptor alpha [28] and the aromatase 
gene [8] gave the opportunity to compare the role of 
estrogens on human male reproductive function to that of 
animal models. 
Recently, in vitro, in vivo and immunoistochemical stu- 
dies, together with animal and human models of estrogen 
deficiency, provided preliminary data useful for elucida- 
ting also the mechanism of estrogen actions on male 
reproductive cells [1, 19, 23]. 
I I .  ESTROGEN ACT IONS 
In males estrogens derive from circulating androgens via 
aromatization by the aromatase nzyme (Ar). Estrogen 
actions are mediated by the binding to specific nuclear 
receptors (ERs), which are transcription factors that regu- 
late the expression of target genes after hormone binding 
[12]. Two subtypes of ERs have been described: estrogen 
receptor c~ (ERa) and estrogen receptor 13 (ERB). Estro- 
gens exert heir actions on the cell through a nuclear inter- 
action after binding their receptors. A rapid, nongenomic 
action of estrogens, mediated through cell-surface recep- 
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tors, which are not believed to act via a transcriptional 
mechanism [12] does exist, accounting for some estrogen 
actions which need to be clarified in detail. 
I I I .  D ISTR IBUT ION OF  ESTROGEN RECEP-  
TORS (ERs)  AND AROMATASE (Ar) IN THE 
MALE REPRODUCTIVE  SYSTEM 
ERs and Ar are widely expressed in the male reproductive 
tract in both animals and humans. The demonstration at 
this level of the presence of both the Aromatase nzyme 
and ERs implies that estrogen biosynthesis does occur in 
the male reproductive tract and that both locally produced 
and circulating estrogens may interact with ERs in an 
intracrine/paracrine and/or endocrine fashion [1, 6, 8, 12, 
19, 22, 23, 28]. Thus, estrogen action on male reproductive 
tract is strongly supported since male reproductive structu- 
res are able to produce and to respond to estrogens [ 1, 6, 8, 
12, 19, 22, 23, 28]. 
1. ERs and Ar in the rodent testis. 
During prenatal life, ER alpha is abundantly expressed in 
the developing ductules and epididymis, but it's not well 
established if it's present within the seminiferous tubules. 
In adult rat and mouse, ER alpha is expressed in the Ley- 
dig cells, but not in Sertoli cells. It seems that ER alpha is 
also expressed in adult rodent germ cells even though it 
has to be confirmed by further studies [6, 22]. 
ER beta is found very early in the gonocytes, Sertoli cells 
and Leydig cells, showing the gonocytes the higher expres- 
sion. ER beta is widely expressed by the rat seminiferous 
epithelium (Sertoli cells and germ cells) as well as by Ley- 
dig cells, efferent ductules and epididymis. ER beta seems 
to be the only ER in germ cells: it is found in pachytene 
spermatocytes, round spermatids, and perhaps in elongated 
spermatids. ER beta is expressed in Leydig, Sertoli and 
germ cells in adult mice. In the male reproductive tract, ER 
beta distribution is inversely related to that of ER alpha, 
showing a progressive increase from proximal to distal 
ducts. ER alpha has a functional role in the mouse rete tes- 
tis and efferent ductules as demonstrated in ~ERKO mice 
and in normal mice treated with an estrogen receptor anta- 
gonist [18]. 
Ar is expressed in both Leydig and Sertoli cells in the 
rodent fetal testis, but not in gonocytes and immature 
structure of seminal tract. Ar is expressed by the Sertoli 
cells at the time when FSH receptor is expressed too; fetal 
Leydig cells have also the ability to produce estrogens in 
response to LH, but aromatase from this cell-type is 
expressed to a lesser degree in fetal and neonatal rats. 
Germ cells do not express aromatase during prenatal life, a 
phenomenon which will become of great importance only 
in the adult rodent testes. By adulthood, rodent Leydig 
cells show a higher aromatase activity with respect o 
every other age and in comparison to Sertoli cells. 
Aromatase too is expressed at a high level in germ cells 
throughout all stages of maturation and its expression 
appears to be higher as the immature germ cell becomes a
mature spermatid [22]. 
It is not well established whether aromatase is expressed in
the seminal tract of adult rodents. 
2. ERs and Ar in the human testis 
Both ERs have been found in human testis and reproducti- 
ve tract. In the male fetus ER beta expression is higher 
than ER alpha, being the latter absent or expressed at very 
low levels. Particularly in the human fetus ER beta is pre- 
sent in the seminiferous epithelium (Sertoli cells and few 
germ cells) and in the epididymis, while ER alpha is unde- 
tectable in these structures, thus suggesting a major role of 
ER beta during prenatal development and function of male 
reproductive structures [30]. 
In adult men, ER alpha is expressed only in Leydig cells, 
while ER beta has been found in the efferent ducts. No 
ERs have been detected in the epididymis. Besides ER 
beta was documented in both Leydig and Sertoli cells [6, 
22]. 
Ar expression in the human testis involves both somatic 
and germ cells from pachytene spermatocytes through 
elongated spermatids. Ar is also expressed in both human 
Leydig and Sertoli cells. Recently it has been demonstrated 
the presence of aromatase gene not only in immature germ 
cells but also in completely mature human spermatozoa [5, 
16, 22]. 
IV. ROLE OF  ESTROGENS ON MALE 
REPRODUCTION 
Our knowledge of the role of estrogens in male reproducti- 
ve system has been significantly improved by the creation 
of knock-out ransgenic mice models lacking functional 
ER alpha, ER beta or Aromatase gene (o~ERKO, fSERKO, 
ArKO mice respectively). 
Adult, sexually mature, o~ERKO mice are infertile even 
though the development of the male reproductive tract is 
unaffected [6]. The adult histological picture of c~ERKO 
male mice testes is characterized by atrophic and degene- 
rating seminiferous epithelium together with dilated tubu- 
les and a dilation of the rete testis. Damage of testicular 
tissue becomes evident at about 40-60 days, when the 
tubules are completely dilated with a corresponding signi- 
ficant increase of testicular volume and when the seminife- 
rous epithelium becomes atrophic [6, 15]. A severe impair- 
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ment in tubular fluid absorption in the efferent ducts was 
demonstrated to be the cause of infertility in o~ERKO male 
mice; this probably derives from the interaction of estro- 
gens to ER alpha which causes a progressive swelling of 
the seminiferous tubules as a consequence of tubular dila- 
tation. This process results in a severe impairment of sper- 
matogenesis, coupled with testicular atrophy [6, 15]. 
ArKO mice are initially fully fertile [11], but fertility 
decreases with advancing age [24] and conversely BERKO 
mice are fully fertile and phenotypically normal also 
during adolthood [17]. Histology of the testes of one year 
old ArKo mice shows a disruption of spermatogenesis at 
early spermatogenetic stage, without significant changes in 
the volume of the seminiferous tubules lumen, together 
with Leydig cells hyperplasia [22, 24]. The mechanism 
involved in the development of infertility is different in 
ArKO male mice since the early arrest of spermatogenesis 
suggests a failure of germ cells differentiation probably 
caused by the lack of estrogens in the testicular environ- 
ment. 
Recently, the developement of the ~ISERKO mice, in 
which both alpha and beta estrogen receptor are disrupted, 
showed a male phenotype very close to that of ~ERKO 
mice with infertility and dilated seminiferous tubules. 
From the data shown it seems that functional alpha estro- 
gen receptor, but not beta, is needed for the development 
and maintenance of normal fertility in male mice even 
though beta receptor is widely expressed in the rat didimis 
[6, 22]. 
Some naturally occurred mutations in the estrogen receptor 
or in the aromatase gene in human males helped us unders- 
tanding the role of estrogens in the regulation of the hypo- 
thalamo-pituitary-gonadal xis in the human male [26] 
(Table 1). 
Data obtained from men affected by congenital estrogen 
deficiency have provided conflicting and confused results 
concerning fertility rate (Table 1). The only man with 
estrogen resistance discovered up to now, a human equiva- 
lent of the ERKO mice, had normal testis volume and nor- 
mal sperm count with slightly reduced motility [28]. The 
four adult male patients affected by congenital aromatase 
deficiency showed a variable degree of impaired spermato- 
genesis [3, 4, 14; 20, 21, 26]. The patient described by 
Carani et al., showed both a severely reduced sperm count 
and an impairment of sperm viability with germ cell arrest 
at the level of primary spermatocytes [4]. In a new patient 
a complete germ cell arrest was documented by the biopsy 
of the testis even though semen analysis was not perfor- 
med because of the patient's religious beliefs. In this 
patient a surgically treated bilateral cryptorchidism has 
been documented atthe medical history [20]. Data concer- 
ning the patient described by Morishima et al. are lacking 
since sperm was not analyzed [3, 21 ]. Another patient with 
congenital aromatase deficiency showed oligoastheno- 
zoospermia. However in this patient another genetic disor- 
der cannot be rouled out since his brother who had a nor- 
mal aromatase enzyme xpression had the same alterations 
in semen analysis [14]. Of interest, it should be remarked 
that a clear cause-effect relationship between infertility and 
aromatase deficiency is not demonstrable also in the 
patient studied by Carani et al., since also one of his bro- 
thers was infertile despite the absence of mutations in the 
aromatase gene [4]. 
The variable degree of fertility impairment in men with 
congenital estrogen deficiency (Table 1) does not permit a 
conclusive demonstration f a direct relationship between 
estrogen deficiency and infertility, even though a possible 
role of estrogen on human spermatogenesis is strongly 
suggested. Recently, in fact, the administration f aromata- 
se inhibitors to infertile men with an impaired testosterone 
to estradiol ratio, with high estradiol levels, resulted in an 
improvement of the spermatic parameters [23]. Thus these 
data together with the demonstration f aromatase activity 
in human ejaculated spermatozoa [1] suggest a role for 
estrogen also in human male reproduction. 
V. ESTROGEN AND THE REGULAT ION OF  
GONADOTROPIN  SECRET ION IN 
THE MALE 
Studies performed on normal and GnRH deficient men 
showed that testolactone administration prevented the tes- 
tosterone-induced LH suppression in normal men [9]. 
These same effects appeared evident in GnRH-deficient 
men whose gonadotropin secretion had been normalized 
by pulsatile GnRH infusion [9]. This raised the possibility 
of a suppressive effect of estradiol on LH secretion at least 
at the pituitary level [9, 10]. 
The administration of dihydrotestosterone, a nonaromati- 
zable androgen, in normal men, did not induce a reduction 
in gonadotropin secretion [2]. 
Estrogen have also been showed to decrease GnRH pulse 
frequency at hypotalamic level and to reduce GnRH 
responsiveness at the pituitary level [13]. Since no ERs, at 
least of the alpha subtype, have been found in GnRH 
secreting neurons [29], the issue of the precise mechanism 
of action of estrogen in the regulation of the hypotalamo- 
pituitary-gonadal axis in the male still remains open. 
The study of men with aromatase deficiency shows that 
estrogens, rather than androgens are the principal regula- 
tors of gonadotropin feedback, acting both on basal gona- 
dotropin secretion (Table 1) and on gonadotropin respon- 
siveness to GnRH [14, 20, 21, 25]. 
In a young patient affected by congenital aromatase deft- 
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Table 1 : Reproductive phenotypes of  men with congenital estrogen deficiency. 
ESTROGEN RESISTANCE AROMATASE DEFICIENCY 
LH Increased [28] 1) Increased [21] 
2) Normal-increased [4] 
3) Normal [20] 
4) Normal [14] 
FSH Increased [28] 1 ) Increased [21 ] 
2) Increased [4] 
3) Increased [20] 
4) Increased [14] 
Testosterone Normal [28] 1) Increased [21] 
2) Normal [4] 
3) Low-normal [20] 
4) Increased [ 14] 
Estradiol Normal [28] 1) Undetectable [21 ] 
2) Undetectable [4] 
3) Undetectable [20] 
4) Undetectable [ 14] 
Semen Analysis Sperm count : 25 x 106/mL 1) Not performed [21 ] 
Viability : 18% [28] 2) Sperm count : lx l06/mL 
Viability : 0% [4] 
3) Not performed [20] 
4) Sperm count : 17.4x106/mL 
Viability : 55% [14] 
Gender Identity Male [28] Male [6, 8, 27, 28] 
Sexual Orientation Heterosexual [28] Heterosexual [6, 8, 27, 28] 
ciency no alterations were found in gonadotropin secretion 
[7]. This finding rises the possibility that the role of estro- 
gens on the hypotalamo-pituitary-testicular axis becomes 
relevant in a later stage of life than infancy [8, 25, 26]. 
VI.  CONCLUSIONS 
In conclusion, estrogens eem to play an important role 
in the regulation of male reproductive function. Estro- 
gens are major regulators of gonadotropin secretion 
not only at the pituitary level but also at the hypotala- 
mic level. Their actions on the regulation of testicular 
function and spermatogenesis can be hypothesized by 
the presence of both estrogen receptors and the aroma- 
tase gene in the testis at various levels, but the precise 
role of estrogen in the regulation of spermatogenesis  
still unclear. Further studies are needed to completely 
elucidate the role of estrogens on male reproductive 
function and their possible clinical implications. 
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